Tag: Dr Erik Wambre

AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
Reasearcher

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

What they discover could guide the design of a new strategy for immune intervention.
Research

Th2A: the Key to Unlocking Better Testing and a Cure for...

A look at what all the excitement is about.

Connect with Us

39,074FansLike
738FollowersFollow
2,703FollowersFollow
5,517FollowersFollow
40SubscribersSubscribe